NEW YORK, July 31, 2013 /PRNewswire/ -- Pomerantz
Grossman Hufford Dahlstrom & Gross LLP is investigating claims
on behalf of investors of Trius Therapeutics, Inc. ("Trius" or the
"Company") (NASDAQ: TSRX) (ISIN: US89685K1007) (CUSIP: 89685K100)
concerning the proposed acquisition of Trius by Cubist
Pharmaceuticals, Inc. in a transaction valued at $818 million.
The investigation concerns whether the Trius directors are
breaching their fiduciary duties by failing to adequately shop the
Company and maximize shareholder value. Under the terms of
the agreement, Trius shareholders will be entitled to receive
$13.50 per share in cash for each
share of Trius common stock. In addition to the upfront cash
payment, each Trius stockholder will receive one Contingent Value
Right, entitling the holder to receive an additional cash payment
of up to $2.00 for each share they
own if certain commercial sales milestones are achieved.
However, the price to Revenue and Book Value multiples are below
the averages of comparable transactions and at least one analyst
has set a target price of $20.00 per
share for Trius common stock.
Trius shareholders seeking more information about this
acquisition are advised to contact Robert
Willoughby at rswilloughby@pomlaw.com or 212-661-1100 or
888-476-6529, ext. 237.
The firm is also investigating actions on behalf of shareholders
for the following companies: Hilltop Community Bancorp, Inc.,
Dole Food Company, Inc., and Cooper Tire & Rubber Company.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and San
Diego, is acknowledged as one of the premier firms in the
areas of corporate, securities, and antitrust class litigation.
Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the
Pomerantz Firm pioneered the field of securities class actions.
Today, more than 75 years later, the Pomerantz Firm continues in
the tradition he established, fighting for the rights of the
victims of securities fraud, breaches of fiduciary duty, and
corporate misconduct. The Firm has recovered numerous
multimillion-dollar damages awards on behalf of defrauded
investors. See www.pomerantzlaw.com.
CONTACT:
Robert
Willoughby
Pomerantz Grossman Hufford Dahlstrom
& Gross LLP
212-661-1100 ext. 237
rswilloughby@pomlaw.com
SOURCE Pomerantz Grossman Hufford
Dahlstrom & Gross LLP